As the information in this release pertains to EDEN RESEARCH PLC, this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
18 December 2025
Eden Research plc
("Eden" or "the Company")
Appointment of Syngenta as Distribution Partner
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, is pleased to announce the appointment of Syngenta Crop Protection AG ("Syngenta") as the Company's exclusive distribution partner for professional uses in indoor and outdoor ornamental crops ("Ornamentals") in several EU countries and the UK.
Working under a Distribution Agreement ("Agreement"), Eden and Syngenta will register and develop the market for Eden's novel fungicide product, to be marketed by Syngenta as "Evelta™", for uses such as cut flowers, pot plants, trees, shrubs, and bulbs. Eden shall be responsible for, and maintain ownership of, the product registrations, whilst Syngenta will invest in, conduct, and provide access to, the biological efficacy data needed for registration purposes.
Once registered, Eden shall supply finished product to Syngenta who shall then sell to professional ornamental growers using the significant market access it has built up over several decades.
Syngenta is a multinational, science-based agriculture company, empowering farmers to meet the demands of modern agriculture. Using cutting-edge innovation, Syngenta helps farmers to grow resilient, healthy crops that can feed a growing global population, while promoting sustainable farming practices that protect and enhance our planet. Headquartered in Switzerland, Syngenta is a global agritech leader with more than 30,000 employees across over 90 countries.
Sean Smith, Chief Executive Officer of Eden Research, commented:
"We are pleased to have signed our first commercial agreement with one of the world's largest crop protection companies and a true industry leader.
"In the last five years, Eden has partnered with two of the top five crop protection companies globally, which is a strong endorsement of Eden's products, technologies and team. This agreement complements our existing network of important partnerships which we constantly invest in and mange in order to optimise our commercial execution and deliver value for farmers and Eden's stakeholders."
"We very much look forward to working with the Syngenta team to bring Eden's sustainable solutions to new, untapped markets."
-- ENDS --
For further information contact:
|
Eden Research plc |
|
|
Sean Smith |
01285 359 555 |
|
|
|
|
Cavendish Capital Markets Limited |
|
|
Giles Balleny / George Lawson (corporate finance) |
020 7220 0500 |
|
|
|
|
Oberon Capital (Joint broker) |
|
|
Nick Lovering Mike Seabrook Adam Pollock |
020 3179 5300 |
|
|
|
|
Hawthorn Advisors (Financial PR) |
|
|
Victoria Ainsworth |
eden@hawthornadvisors.com |
Notes to Editors:
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:
Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops. It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.
Novellus®+ is an evolution of Mevalone, allowing improved rates in the field, high levels of efficacy and a broader list of targets.
Cedroz™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.
Eden's seed treatment product, Ecovelex™ was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, US and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.
Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease of use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.
Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.
For more information about Eden, please visit: www.edenresearch.com. You can also follow Eden's latest developments via its social media channels: X (Twitter) and LinkedIn.
For more information about Syngenta, please visit: https://www.syngenta.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.